4D-150 in Patients With Diabetic Macular Edema
Study sponsor: 4D Molecular Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2029-02-28Estimated
Enrollment · participants72Estimated
Source updated2026-08-21Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.